Loss of Chromosome 17p

8 clinical trials · Condition

Record	Firm	Date
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies (NCT03272633)	Rutgers, The State University of New Jersey	2020-10-26
Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance (NCT03943342)	Kerry Rogers	2020-03-11
a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients (NCT04008888)	Institute of Hematology & Blood Diseases Hospital, China	2018-01-05
Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma (NCT02633059)	Mayo Clinic	2015-12-30
Nivolumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or High-Risk Untreated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Richter Transformation (NCT02420912)	M.D. Anderson Cancer Center	2015-06-19
Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies (NCT01527045)	Fred Hutchinson Cancer Center	2012-09-25
Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma (NCT01163357)	City of Hope Medical Center	2011-01-28
Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia (NCT01008462)	Fred Hutchinson Cancer Center	2010-03-18

Track Loss of Chromosome 17p automatically

Every clearance here is in the API, with alerts when new ones post.